Afiba Manza-A Agovi1,2, Ifedioranma Anikpo1, Matthew J Cvitanovich1, Esther O Fasanmi3,4, Rohit P Ojha1,2, Julia L Marcus5. 1. Center for Epidemiology & Healthcare Delivery Research, JPS Health Network, Fort Worth, TX. 2. Department of Medical Education, TCU and UNTHSC School of Medicine, Fort Worth, TX. 3. Pharmacy Clinical Services Outpatient, JPS Health Network, Fort Worth, TX. 4. Healing Wings Infectious Disease Clinic, JPS Health Network, Fort Worth, TX; and. 5. Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.
Abstract
INTRODUCTION: Safety-net health systems are key settings for HIV pre-exposure prophylaxis (PrEP) implementation, but little evidence is available about the frequency of PrEP prescribing in safety-net settings. We assessed PrEP prescribing among people with indications for PrEP at an urban safety-net health system that serves a county designated as an Ending the HIV Epidemic priority jurisdiction. METHODS: We identified adults (aged 18 years or older) who engaged in primary care between January 2015 and December 2019 and had a documented indication for PrEP. PrEP indications included the presence of a behavioral or sexual risk factor of HIV acquisition or a positive bacterial sexually transmitted infection at the index visit. PrEP prescribing was defined as the proportion of patients with indications for PrEP who received a new prescription for PrEP. We estimated the cumulative incidence of PrEP prescription with corresponding 95% confidence limits (CL). RESULTS: Our study population comprised 2957 individuals, of whom 58% was aged younger than 45 years, 56% was women, 67% was racial or ethnic minorities, and 60% was uninsured or provided care as part of a hospital-based managed care plan for individuals without insurance. We identified 41 individuals who were prescribed PrEP. The cumulative incidence of PrEP prescribing within 1 year of the first documented PrEP indication was 1.3% (95% CL: 0.91% to 1.7%). CONCLUSIONS: Our results suggest extremely low frequency of PrEP prescribing among people with indications for PrEP in an urban safety-net health system. Strategies are needed to improve PrEP implementation in high-priority populations and safety-net settings.
INTRODUCTION: Safety-net health systems are key settings for HIV pre-exposure prophylaxis (PrEP) implementation, but little evidence is available about the frequency of PrEP prescribing in safety-net settings. We assessed PrEP prescribing among people with indications for PrEP at an urban safety-net health system that serves a county designated as an Ending the HIV Epidemic priority jurisdiction. METHODS: We identified adults (aged 18 years or older) who engaged in primary care between January 2015 and December 2019 and had a documented indication for PrEP. PrEP indications included the presence of a behavioral or sexual risk factor of HIV acquisition or a positive bacterial sexually transmitted infection at the index visit. PrEP prescribing was defined as the proportion of patients with indications for PrEP who received a new prescription for PrEP. We estimated the cumulative incidence of PrEP prescription with corresponding 95% confidence limits (CL). RESULTS: Our study population comprised 2957 individuals, of whom 58% was aged younger than 45 years, 56% was women, 67% was racial or ethnic minorities, and 60% was uninsured or provided care as part of a hospital-based managed care plan for individuals without insurance. We identified 41 individuals who were prescribed PrEP. The cumulative incidence of PrEP prescribing within 1 year of the first documented PrEP indication was 1.3% (95% CL: 0.91% to 1.7%). CONCLUSIONS: Our results suggest extremely low frequency of PrEP prescribing among people with indications for PrEP in an urban safety-net health system. Strategies are needed to improve PrEP implementation in high-priority populations and safety-net settings.
Authors: Courtney R Lyles; Margaret A Handley; Sara L Ackerman; Dean Schillinger; Pamela Williams; Marisa Westbrook; Gato Gourley; Urmimala Sarkar Journal: Am J Med Qual Date: 2018-09-10 Impact factor: 1.852
Authors: Benedikt Pleuhs; Katherine G Quinn; Jennifer L Walsh; Andrew E Petroll; Steven A John Journal: AIDS Patient Care STDS Date: 2020-02-28 Impact factor: 5.078
Authors: Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu Journal: AIDS Patient Care STDS Date: 2019-12 Impact factor: 5.078
Authors: George L Jackson; Benjamin J Powers; Ranee Chatterjee; Janet Prvu Bettger; Alex R Kemper; Vic Hasselblad; Rowena J Dolor; R Julian Irvine; Brooke L Heidenfelder; Amy S Kendrick; Rebecca Gray; John W Williams Journal: Ann Intern Med Date: 2013-02-05 Impact factor: 25.391
Authors: Maria Pyra; Laura K Rusie; Kristin Keglovitz Baker; Andie Baker; Jessica Ridgway; John Schneider Journal: Am J Public Health Date: 2020-01-16 Impact factor: 9.308